Effect Of Vegan Fecal Microbiota Transplantation On Carnitine‐ And Choline‐Derived Trimethylamine‐N‐Oxide Production And Vascular Inflammation In Patients With Metabolic Syndrome

This study investigated whether changing the gut bacteria in people with metabolic syndrome could help protect their hearts. Scientists know that certain gut bacteria convert compounds found in meat and eggs (choline and carnitine) into a substance called TMAO, which may increase the risk of heart disease. Since vegans typically have lower TMAO levels and different gut bacteria, researchers wondered if transplanting vegan gut bacteria into metabolic syndrome patients might offer cardiovascular benefits.

The researchers conducted a small study with 20 men who had metabolic syndrome. Half received a fecal microbiota transplant (FMT) from a lean vegan donor, while the other half received their own bacteria back as a control. The team measured the patients' ability to produce TMAO from dietary compounds, examined their gut bacteria composition, and assessed vascular inflammation using specialized imaging and blood tests.

While some patients who received the vegan donor transplant did show changes in their gut bacteria composition that resembled a vegan profile, this didn't translate into the hoped-for benefits. The treatment failed to reduce TMAO production, decrease vascular inflammation, or improve other markers of heart health. The single transplant simply wasn't enough to create lasting, beneficial changes.

This research highlights both the promise and challenges of using gut microbiome interventions for metabolic health. While the connection between gut bacteria and heart disease is real, simply transplanting "healthier" bacteria may not be sufficient—the underlying diet, lifestyle, and gut environment likely need to change too. For clinical practice, this suggests that comprehensive lifestyle interventions focusing on diet and gut health may be more effective than microbiome transplants alone for improving cardiovascular risk in metabolic syndrome patients.